Safe cosmetic formulation involves far more than combining ingredients. It is a structured process grounded in scientific evaluation and strict regulatory compliance. In major markets such as the European Union, manufacturers must ensure that cosmetic products remain safe for human health under normal and reasonably foreseeable conditions of use.
This approach places consumer safety at the center of product development and requires continuous alignment with legal and scientific requirements.
Regulatory Compliance as the Basis of Formulation
Regulatory compliance forms the foundation of safe cosmetic formulation. In the European Union, Regulation (EC) No 1223/2009 governs all cosmetic products placed on the market. This regulation requires a thorough safety assessment of each ingredient and the finished product before market entry.
Formulators must work within a clearly defined legal framework that controls which substances they may use and under what conditions. Compliance begins at the earliest stages of product development and continues throughout the product lifecycle.
COSING Database and Regulatory Annexes
The COSING database serves as a primary regulatory reference for cosmetic formulators in the EU. It provides detailed information on the legal status and permitted functions of cosmetic ingredients.
COSING allows formulators to verify whether a substance is permitted, restricted, or prohibited for cosmetic use. This step is essential before selecting any raw material.
The Cosmetic Regulation includes several annexes that define substance-specific requirements. Annex II lists substances prohibited in cosmetic products. Annex III specifies restricted substances and outlines conditions such as maximum concentration limits, product types, and warnings. Annexes IV to VI list approved colorants, preservatives, and UV filters that may be used exclusively under defined conditions.
Scientific Safety Assessment and the Role of SCCS
Scientific evaluation supports regulatory compliance and ensures ingredient safety. The Scientific Committee on Consumer Safety (SCCS) plays a key role by assessing toxicological data and issuing opinions on cosmetic ingredients.
The SCCS evaluates exposure scenarios, potential health risks, and safe concentration levels. Its opinions often lead to regulatory updates and amendments to the annexes of the Cosmetic Regulation.
Active ingredients such as alpha hydroxy acids (AHAs) highlight the importance of scientific oversight. AHAs provide effective exfoliation but may cause skin irritation or increase photosensitivity if misused. For this reason, Annex III restricts their use, often defining maximum concentrations and minimum pH values, such as limits around 10 percent and pH levels above 3.5, to protect consumer safety.
The Formulator’s Responsibilities in Safe Cosmetic Design
Formulators carry direct responsibility for ensuring product safety and compliance. This responsibility extends across several critical activities.
They must confirm the regulatory status of each ingredient and ensure usage levels remain within permitted limits defined by COSING and the regulatory annexes. They must also support a comprehensive Cosmetic Product Safety Report (CPSR) that evaluates toxicological profiles, ingredient interactions, and foreseeable misuse scenarios, such as accidental eye exposure.
In addition, formulators must verify product stability and microbiological safety through appropriate laboratory testing. Stability studies confirm that the product maintains its quality throughout its shelf life, while microbiological testing ensures adequate protection against contamination.
Ensuring Safe and Compliant Cosmetic Products
By integrating regulatory requirements with scientific guidance from the SCCS, formulators can develop innovative cosmetic products without compromising consumer health. Safe cosmetic formulation depends on careful ingredient selection, validated safety assessments, and continuous regulatory awareness. This structured approach ensures that cosmetic products meet both legal obligations and high safety standards before reaching the consumer.
Ensure your cosmetic formulations meet EU safety and compliance standards. Contact our experts for ingredient review and safety assessment support. Get in touch!
Designing for compliance from the first bench trial
Compliance is far cheaper to build in than to retrofit. Most expensive regulatory problems are created at bench stage, months before anyone reads the Regulation, and they surface only when the safety assessor sees the formulation.
Three checks at formulation stage prevent the majority of them. Screen every raw material against the Annexes before it enters a trial, so a prohibited or restricted substance never becomes structural to the formula. Confirm each ingredient’s concentration against its restriction limit, since many substances are permitted but capped, and the cap often varies by product type and by whether the product is leave-on or rinse-off. And collect the supplier documentation — Safety Data Sheet, Certificate of Analysis, Technical Data Sheet, allergen and IFRA declarations — as materials are selected rather than months later.
That last point is the most common cause of delay in practice. A safety assessment cannot begin without complete raw material documentation, and chasing a supplier for an allergen breakdown after the formulation is locked routinely adds weeks to a launch.
The preservative system decision
For any product containing water, the preservative system is the single decision with the widest downstream consequences. It determines whether the product passes challenge testing, what Period After Opening can be justified, and how vulnerable the formula is to future Annex amendments.
Only preservatives listed in Annex V may be used for preservative purposes, each within its stated concentration limit and conditions. Effective preservation normally requires broad-spectrum coverage against bacteria, yeast and mould, which usually means a combination rather than a single ingredient. pH matters as much as choice: several widely used preservatives lose activity outside a defined pH range, so a formula adjusted for skin feel can quietly disable its own preservation.
Marketing constraints deserve honest scrutiny here. “Preservative-free” and similar positioning frequently pushes formulators toward multifunctional ingredients used at levels that do not reliably protect the product. A formulation that fails challenge testing has to be reworked and retested, which costs more than the marketing angle is usually worth — and claims that denigrate legally permitted preservatives can themselves breach the fairness criterion for claims.
Formulation choices that create compliance problems
Some decisions look harmless at bench stage and become expensive later:
- Heavy use of essential oils, which drives the allergen declaration up and can breach Annex III limits on individual constituents
- Botanical extracts supplied in aqueous or glycol carriers, which introduce water into a formula intended to be anhydrous and remove the challenge test exemption
- Nano-form pigments or UV filters, which trigger both the [nano] label suffix and a separate notification six months before market
- Formulating around an ingredient already under SCCS review, which risks reformulating again within a year or two
- Building a product around a performance claim with no realistic way to substantiate it
The common thread is that formulation, testing, labelling and claims are one connected system rather than four sequential stages. A change in any of them propagates through the others, which is why involving the safety assessor before the formula is locked reliably costs less than involving them afterwards.
Frequently asked questions
Can I use any preservative I like?
No. Only substances listed in Annex V may be used to preserve a cosmetic, and each carries a maximum concentration and conditions of use. Some are additionally restricted by product type or prohibited in products for young children.
Are natural ingredients easier to get approved?
No, and often the opposite. Natural extracts are complex mixtures, frequently carry a high allergen load, and can be more variable batch to batch, which makes both the safety assessment and stability harder rather than easier.
When should I involve a safety assessor?
Before the formulation is finalised. An assessor reviewing a draft formula can flag restricted substances and concentration issues while they are still cheap to change; reviewing a locked formula after testing has been paid for is far more expensive.
Does changing a raw material supplier require reassessment?
Often yes. Grade, purity and minor constituents can differ between sources in ways that affect both safety and stability, so a supplier change should be assessed rather than assumed equivalent.
